(Q39408982)

11 September 2017

title

Cord blood stem-cell-derived dendritic cells generate potent antigen-specific immune responses and anti-tumour effects (English)

1 reference

11 September 2017

1 reference

2

1 reference

11 September 2017

Ying-Cheng Chiang

4

1 reference

ORCID Public Data File 2021

author name string

Ming-Cheng Chang

1

1 reference

11 September 2017

Yu-Li Chen

3

1 reference

11 September 2017

Wei-Zen Sun

5

1 reference

11 September 2017

Yu-Hao Hu

6

1 reference

11 September 2017

Chi-An Chen

7

1 reference

11 September 2017

Wen-Fang Cheng

8

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 September 2012

1 reference

11 September 2017

1 reference

11 September 2017

volume

123

1 reference

11 September 2017

issue

6

1 reference

11 September 2017

page(s)

347-360

1 reference

Dendritic cells as vectors for therapy

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCS20110272

Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110272

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110272

Generation of interferon alpha-producing predendritic cell (Pre-DC)2 from human CD34(+) hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110272

Isolation of broadly reactive, tumor-specific, HLA Class-I restricted CTL from blood lymphocytes of a breast cancer patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110272

CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110272

Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110272

CD8+ T cells, NK cells and IFN-gamma are important for control of tumor with downregulated MHC class I expression by DNA vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110272

Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110272

Dendritic cell vaccination in patients with malignant gliomas: current status and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110272

Recent advances in immunotherapy for human glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110272

Human tumor-derived genomic DNA transduced into a recipient cell induces tumor-specific immune responses ex vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110272

Progress in cancer vaccines by enhanced self-presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110272

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110272

Dendritic cells as therapeutic vaccines against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110272

Induction of proliferation and monocytic differentiation of human CD34+ cells by CD137 ligand signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110272

De novo T-lymphocyte responses against baculovirus-derived recombinant influenzavirus hemagglutinin generated by a naive umbilical cord blood model of dendritic cell vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110272

Antitumor activity of a fusion of esophageal carcinoma cells with dendritic cells derived from cord blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110272

In vitro priming and expansion of cytomegalovirus-specific Th1 and Tc1 T cells from naive cord blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110272

Dendritic Cell-Based Immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110272

21 January 2018

Identifiers

DOI

10.1042/CS20110272

1 reference

11 September 2017

1 reference